Secondary Parkinsonism Latest Advances

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Journal: Neurology

Published: January 09, 2026

Neuroprotective Effect of D-Pinitol Against MPTP-Induced Parkinsonism in C57BL/6J Mice.

Journal: Antioxidants (Basel, Switzerland)

Published: December 01, 2025

Acupuncture for Mild Cognitive Impairment in Vascular Parkinsonism: A Prospective, Randomized, Controlled Trial Protocol.

Journal: Neuropsychiatric disease and treatment

Published: December 01, 2025

The protective effect of febuxostat in a rotenone mouse model of Parkinson's disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways.

Journal: The Journal of pharmacy and pharmacology

Published: November 16, 2025

When levodopa resistance does not indicate disease progression: a case of coexisting Parkinson's disease and secondary Parkinsonism due to demyelinating lesions.

Journal: Acta neurologica Belgica

Published: November 16, 2025

Sinking Bone Flap Syndrome Presenting as Parkinsonism: A Case Report.

Journal: Movement disorders clinical practice

Published: November 13, 2025

Drug-Induced Parkinsonism: A Structured, Mechanism-Informed Approach to Identification and Management.

Journal: Cureus

Published: October 19, 2025

Cycloastragenol Derivatives Improve Tyrosine Metabolism, Regulate TLR4/NF-κB/TERT Signaling Pathways, and Inhibit MPTP Induced Neuroinflammation and PD Symptoms.

Journal: CNS neuroscience & therapeutics

Published: October 13, 2025

Neuroprotective Effects of Intranasally Administered Octadecaneuropeptide Analog in a Mouse Model of MPTP-Induced Parkinson's Disease.

Journal: Journal of visualized experiments : JoVE

Published: September 15, 2025

Montelukast Modulates MPTP-induced Ferroptosis and Neuroinflammation Linked To the GPX4/ACSL4/5-LOX Pathway.

Journal: Neuromolecular medicine

Published: August 30, 2025

RRx-001 ameliorates astrocyte pyroptosis by regulating LCN2-NLRP3 inflammasome activation in an MPTP-induced parkinson's disease mouse model.

Journal: Cellular and molecular life sciences : CMLS

Published: August 30, 2025

The role of BDNF/PI3K/AKT/Nrf2 signaling in nicotine's protective effects against MPTP-induced Parkinson's disease.

Journal: Neuroscience letters

Published: August 29, 2025

Secondary Parkinsonism Latest Advances

Find the Latest Research About Secondary Parkinsonism

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Neuroprotective Effect of D-Pinitol Against MPTP-Induced Parkinsonism in C57BL/6J Mice.

Neuroprotective Effect of D-Pinitol Against MPTP-Induced Parkinsonism in C57BL/6J Mice.

Acupuncture for Mild Cognitive Impairment in Vascular Parkinsonism: A Prospective, Randomized, Controlled Trial Protocol.

Acupuncture for Mild Cognitive Impairment in Vascular Parkinsonism: A Prospective, Randomized, Controlled Trial Protocol.

The protective effect of febuxostat in a rotenone mouse model of Parkinson's disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways.

The protective effect of febuxostat in a rotenone mouse model of Parkinson's disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways.

When levodopa resistance does not indicate disease progression: a case of coexisting Parkinson's disease and secondary Parkinsonism due to demyelinating lesions.

When levodopa resistance does not indicate disease progression: a case of coexisting Parkinson's disease and secondary Parkinsonism due to demyelinating lesions.

Sinking Bone Flap Syndrome Presenting as Parkinsonism: A Case Report.

Sinking Bone Flap Syndrome Presenting as Parkinsonism: A Case Report.

Drug-Induced Parkinsonism: A Structured, Mechanism-Informed Approach to Identification and Management.

Drug-Induced Parkinsonism: A Structured, Mechanism-Informed Approach to Identification and Management.

Cycloastragenol Derivatives Improve Tyrosine Metabolism, Regulate TLR4/NF-κB/TERT Signaling Pathways, and Inhibit MPTP Induced Neuroinflammation and PD Symptoms.

Cycloastragenol Derivatives Improve Tyrosine Metabolism, Regulate TLR4/NF-κB/TERT Signaling Pathways, and Inhibit MPTP Induced Neuroinflammation and PD Symptoms.

Neuroprotective Effects of Intranasally Administered Octadecaneuropeptide Analog in a Mouse Model of MPTP-Induced Parkinson's Disease.

Neuroprotective Effects of Intranasally Administered Octadecaneuropeptide Analog in a Mouse Model of MPTP-Induced Parkinson's Disease.

Montelukast Modulates MPTP-induced Ferroptosis and Neuroinflammation Linked To the GPX4/ACSL4/5-LOX Pathway.

Montelukast Modulates MPTP-induced Ferroptosis and Neuroinflammation Linked To the GPX4/ACSL4/5-LOX Pathway.

RRx-001 ameliorates astrocyte pyroptosis by regulating LCN2-NLRP3 inflammasome activation in an MPTP-induced parkinson's disease mouse model.

RRx-001 ameliorates astrocyte pyroptosis by regulating LCN2-NLRP3 inflammasome activation in an MPTP-induced parkinson's disease mouse model.

The role of BDNF/PI3K/AKT/Nrf2 signaling in nicotine's protective effects against MPTP-induced Parkinson's disease.

The role of BDNF/PI3K/AKT/Nrf2 signaling in nicotine's protective effects against MPTP-induced Parkinson's disease.